$MSOS

TerrAscend Corp. reported stronger-than-expected earnings for Q4 2025, driven by increased sales across its cannabis product lines. The company has expanded its market presence, capturing significant market share in the Northeastern US. Despite some ongoing regulatory challenges, management remains optimistic about future growth prospects. Investors reacted positively to the earnings call, with stock prices trending upward post-announcement. Overall, the results reflect a solid operational performance and a positive outlook for the cannabis sector.

The article discusses the anticipated rescheduling of cannabis from its current classification, suggesting that it's now a question of 'when' it will occur rather than 'if'. This rescheduling is expected to pave the way for increased legitimacy and market access for cannabis companies. With potential federal legalization on the horizon, investor interest in cannabis-related stocks is likely to increase. The article highlights several companies that stand to benefit significantly from these changes. Overall, the cannabis industry may experience a surge in valuations as regulatory environments shift favorably.